 |
|
Modeling of endothelial cell dysfunction using human induced pluripotent stem cells derived from patients with end-stage renal disease
Kyoung Woon Kim, Yoo Jin Shin, Bo-Mi Kim, Sheng Cui, Eun Jeong Ko, Sun Woo Lim, Chul Woo Yang, Byung Ha Chung
Kidney Res Clin Pract. 2021;40(4):698-711. Published online 2021 Oct 20 DOI: https://doi.org/10.23876/j.krcp.20.252
|
|
Citations to this article as recorded by
 Bioengineering Cell Therapy for Treatment of Peripheral Artery Disease
Ngan F. Huang, Brett Stern, Beu P. Oropeza, Tatiana S. Zaitseva, Michael V. Paukshto, Janet Zoldan
Arteriosclerosis, Thrombosis, and Vascular Biology.2024;[Epub] CrossRef CRISPR/Cas9-mediated A4GALT suppression rescues Fabry disease phenotypes in a kidney organoid model
Sheng Cui, Yoo Jin Shin, Xianying Fang, Hanbi Lee, Sang Hun Eum, Eun Jeong Ko, Sun Woo Lim, Eunji Shin, Kang In Lee, Jae Young Lee, Chae Bin Lee, Soo Kyung Bae, Chul Woo Yang, Byung Ha Chung
Translational Research.2023; 258: 35. CrossRef Modeling of Fabry disease nephropathy using patient derived human induced pluripotent stem cells and kidney organoid system
Sheng Cui, Xianying Fang, Hanbi Lee, Yoo Jin Shin, Eun-Sil Koh, Sungjin Chung, Hoon Suk Park, Sun Woo Lim, Kang In Lee, Jae Young Lee, Chul Woo Yang, Byung Ha Chung
Journal of Translational Medicine.2023;[Epub] CrossRef Modeling of FAN1-Deficient Kidney Disease Using a Human Induced Pluripotent Stem Cell-Derived Kidney Organoid System
Sun Woo Lim, Dohyun Na, Hanbi Lee, Xianying Fang, Sheng Cui, Yoo Jin Shin, Kang In Lee, Jae Young Lee, Chul Woo Yang, Byung Ha Chung
Cells.2023; 12(18): 2319. CrossRef
|